Month: December 2010

A recent article in The Wall Street Journal suggests that the confidentiality of doctors’ Medicare billing practices has allowed for instances of enormous fraud and abuse to go unchecked. The article...

Dey, a pharmaceutical manufacturer, has become the fourth drug maker this month to settle allegations involving reporting false and inflated drug prices. Payment from the Medicare and Medicaid programs...

December has been a significant month in terms of False Claims Act recoveries from pharmaceutical companies. Three drug makers – Abbott Laboratories Inc., Roxane Laboratories Inc. and B. Braun Medical...

Does it seem as though every day there’s another report of a drug company paying millions to settle allegations of off-label promotion, poor manufacturing practices or overcharging the government?...

Business lobbyists are working overtime to kill the new Securities and Exchange Commission whistle-blower program in a tried-and-true Washington way: Convince the agency to issue regulations that render...

The Commodities Futures Trading Commission is facing a lot of hurdles, including a lack of resources. But it has been moving quickly to draft rules mandated by the Dodd-Frank law. That law gave the CFTC...

If you thought the depths of pharma corruption bottomed out at marketing fraud, pricing fraud or scientific fraud, you’ll be interested in this stunning revelation: Pfizer hired investigators to...

Article by Erika A. Kelton published in The Washington Post, 12/13/2010. Washington’s business lobby has sprung into action to kill the new Securities and Exchange Commission whistle-blower program...

LAFAYETTE, LOUISIANA, December 7, 2010 – The federal government announced today that Kos Pharmaceuticals Inc. has agreed to pay $41.5 million to settle a criminal fine and related civil fraud charges,...